133 related articles for article (PubMed ID: 30938091)
1. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.
Spare LK; Falsetta P; Gilbert J; Harman DG; Baker MA; Li F; McCluskey A; Clegg JK; Sakoff JA; Aldrich-Wright JR; Gordon CP
ChemMedChem; 2017 Jan; 12(2):130-145. PubMed ID: 27921386
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
4. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
5. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
6. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of a series of norcantharidin analogues.
Tarleton M; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2012 Aug; 54():573-81. PubMed ID: 22796041
[TBL] [Abstract][Full Text] [Related]
8. Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro.
Baker JR; Gilbert J; Paula S; Zhu X; Sakoff JA; McCluskey A
ChemMedChem; 2018 Jul; 13(14):1447-1458. PubMed ID: 29771007
[TBL] [Abstract][Full Text] [Related]
9. New Norcantharidin Analogs: Synthesis and Anticancer Activity.
Pachuta-Stec A; Szuster-Ciesielska A
Arch Pharm (Weinheim); 2015 Dec; 348(12):897-907. PubMed ID: 26548647
[TBL] [Abstract][Full Text] [Related]
10. Pyrimidyn-Based Dynamin Inhibitors as Novel Cytotoxic Agents.
Odell LR; Chau N; Russell CC; Young KA; Gilbert J; Robinson PJ; Sakoff JA; McCluskey A
ChemMedChem; 2022 Jan; 17(1):e202100560. PubMed ID: 34590434
[TBL] [Abstract][Full Text] [Related]
11. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
13. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
15. A focused library synthesis and cytotoxicity of quinones derived from the natural product bolinaquinone.
Ghods A; Gilbert J; Baker JR; Russell CC; Sakoff JA; McCluskey A
R Soc Open Sci; 2018 Apr; 5(4):171189. PubMed ID: 29765626
[TBL] [Abstract][Full Text] [Related]
16. Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass.
Galkin KI; Kucherov FA; Markov ON; Egorova KS; Posvyatenko AV; Ananikov VP
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231880
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin analogues: a patent review (2006 - 2010).
Deng L; Tang S
Expert Opin Ther Pat; 2011 Nov; 21(11):1743-53. PubMed ID: 22017412
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of norcantharidin derivatives as protein phosphatase-1 inhibitors.
Zhao J; Guan XW; Chen SW; Hui L
Bioorg Med Chem Lett; 2015 Jan; 25(2):363-6. PubMed ID: 25466711
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
Han HW; Qiu HY; Hu C; Sun WX; Yang RW; Qi JL; Wang XM; Lu GH; Yang YH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3237-3242. PubMed ID: 27262599
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antioxidant Activity of New Norcantharidin Analogs.
Pachuta-Stec A; Nowak R; Pietrzak W; Pitucha M
Chem Biodivers; 2019 Apr; 16(4):e1800673. PubMed ID: 30888741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
